How much does it cost to use Bezutivan for a month?

The cost of the drug is an important consideration for patients considering treatment with Belzutifan. As the world's first HIF-2α inhibitor, the price of this drug has been at a high level in the early stages of its launch. Especially before China has fully included it in medical insurance, its drug cost may put great pressure on some families.

According to the current public information, the recommended dose of besetifan is 120 mg taken orally daily In the Hong Kong market, the drug is sold in the form of imported original research, and the common packaging specification is 40mg*90 tablets, which just covers a 30-day dosage. The current price in the Hong Kong market is as high as hundreds of thousands of yuan per box. This price is mainly due to the multiple overlays of the original brand, patent protection, international transportation and pricing system. There is limited room for price reduction in the short term.

However, the market is not without more affordable alternatives. At present, overseas generic drug versions represented by Laos have become an alternative choice for many patients on the premise of meeting basic drug quality standards. With the same specification of 40mg*90 tablets, the price of the Lao version is around RMB 5,000. The price may fluctuate slightly due to exchange rate fluctuations or supply chain effects. Compared with the price of the original research, this cost is significantly lower, which is especially suitable for patients who require long-term medication management.

Although the active ingredients of generic drugs remain the same as those of the original drugs, patients are advised to obtain them through legal and formal channels and avoid using products from unknown sources to ensure drug efficacy and safety. When choosing generic drugs, you can also consult your doctor to determine whether it is suitable for your own situation. Especially for patients with other underlying diseases or impaired liver and kidney function, careful evaluation should be conducted.

In addition, as besotivan has been officially approved for marketing in mainland China, the price system may be subject to policy intervention in the future. In particular, if medical insurance negotiations or volume purchasing can be advanced quickly, it will greatly reduce the cost of treatment. However, in the short term, before entering the medical insurance catalog, patients still have to bear most of the costs out of their own pocket, and the financial burden cannot be ignored.

Reference materials:https://www.welireg.com/